TCL Archive NCI Stands Firm On Assist “Downscaling” Despite 150 Letters From States, Volunteers January 15, 1993
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic January 17, 2014
TCL Archive Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer January 25, 2013
TCL Archive In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell February 4, 1977